Current Diabetes Reports

, 17:117 | Cite as

A Systematic Approach for the Prevention and Reduction of Hypoglycemia in Hospitalized Patients

  • Paulina Cruz
  • Mary Clare Blackburn
  • Garry S. Tobin
Health Care Delivery Systems and Implementation in Diabetes (ME McDonnell and AR Sadhu, Section Editors)
  • 339 Downloads
Part of the following topical collections:
  1. Topical Collection on Health Care Delivery Systems and Implementation in Diabetes

Abstract

Purpose of Review

Hypoglycemia and severe hypoglycemia (SH) in the inpatient setting are associated with poor outcomes. This review is designed to highlight approaches to predict and prevent inpatient hypoglycemia that has been successfully implemented focusing on developing overlapping policies and procedures that allow safe glycemic management to occur at all levels of the institution.

Recent Findings

Standardizing point-of-care (POC) testing, nursing protocols, meal delivery, and formulary restriction are useful tools to prevent hypoglycemia. Informatics and real-time alert processes are highly effective tools to reduce hypoglycemia but require a significant investment in time and infrastructure as well as clear policies on how alerts are acted upon. Computerized dosing support technology and continuous glucose monitoring (CGM) technology are an emerging area of investigation showing promising results.

Summary

Inpatient hypoglycemia is often predictable and preventable and requires institutional support to deliver targeted and safe diabetes care. This requires each institution to do periodic reassessment of policies and technologies. Future research needs to focus on the cost/benefits of interventions including studies of automated dosing algorithms as well as CGM in higher-risk patient populations.

Keywords

Inpatient hypoglycemia Inpatient diabetes Insulin therapy Prediction and prevention of hypoglycemia 

Notes

Compliance with Ethical Standards

Conflict of Interest

Paulina Cruz Bravo and Mary Clare Blackburn declare that they have no conflict of interest.

Garry S. Tobin reports personal fees from Eli Lilly, Novo Nordisk, Janssen, and MannKind.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Carey M, Boucai L, Zonszein J. Impact of hypoglycemia in hospitalized patients. Curr Diab Rep. 2013;13(1):107–13.CrossRefPubMedGoogle Scholar
  2. 2.
    Akirov A, Grossman A, Shochat T, Shimon I. Mortality among hospitalized patients with hypoglycemia: insulin related and noninsulin related. J Clin Endocrinol Metab. 2017;102(2):416–24.PubMedGoogle Scholar
  3. 3.
    Garg R, Hurwitz S, Turchin A, Trivedi A. Hypoglycemia, with or without insulin therapy, is associated with increased mortality among hospitalized patients. Diabetes Care. 2013;36(5):1107–10.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Turchin A, Matheny ME, Shubina M, Scanlon JV, Greenwood B, Pendergrass ML. Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward. Diabetes Care. 2009;32(7):1153–7.CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    Maynard G, Kulasa K, Ramos P, Childers D, Clay B, Sebasky M, et al. Impact of a hypoglycemia reduction bundle and a systems approach to inpatient glycemic management. Endocr Pract. 2015;21(4):355–67.CrossRefPubMedGoogle Scholar
  6. 6.
    Cryer PE. Hypoglycemia, functional brain failure, and brain death. J Clin Invest. 2007;117(4):868–70.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Schwartz NS, Clutter WE, Shah SD, Cryer PE. Glycemic thresholds for activation of glucose counterregulatory systems are higher than the threshold for symptoms. J Clin Invest. 1987;79(3):777–81.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Thomas M, Sherwin RS, Murphy J, Kerr D. Importance of cerebral blood flow to the recognition of and physiological responses to hypoglycemia. Diabetes. 1997;46(5):829–33.CrossRefPubMedGoogle Scholar
  9. 9.
    Standards of medical care in diabetes—2017: summary of revisions. Diabetes care. 2017;40(Suppl 1):S4–S5.Google Scholar
  10. 10.
    Umpierrez GE, Hellman R, Korytkowski MT, Kosiborod M, Maynard GA, Montori VM, et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(1):16–38.CrossRefPubMedGoogle Scholar
  11. 11.
    Bersoux S, Cook CB, Kongable GL, Shu J, Zito DR. Benchmarking glycemic control in U.S. hospitals. Endocr Pract. 2014;20(9):876–83.CrossRefPubMedGoogle Scholar
  12. 12.
    Brodovicz KG, Mehta V, Zhang Q, Zhao C, Davies MJ, Chen J, et al. Association between hypoglycemia and inpatient mortality and length of hospital stay in hospitalized, insulin-treated patients. Curr Med Res Opin. 2013;29(2):101–7.CrossRefPubMedGoogle Scholar
  13. 13.
    Gomez AM, Umpierrez GE, Munoz OM, Herrera F, Rubio C, Aschner P, et al. Continuous glucose monitoring versus capillary point-of-care testing for inpatient glycemic control in type 2 diabetes patients hospitalized in the general ward and treated with a basal bolus insulin regimen. J Diabetes Sci Technol. 2015;10(2):325–9.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Rubin DJ, Golden SH. Hypoglycemia in non-critically ill, hospitalized patients with diabetes: evaluation, prevention, and management. Hosp Pract. 2013;41(1):109–16.CrossRefGoogle Scholar
  15. 15.
    Budnitz DS, Lovegrove MC, Shehab N, Richards CL. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med. 2011;365(21):2002–12.CrossRefPubMedGoogle Scholar
  16. 16.
    Federico F. Preventing harm from high-alert medications. Jt Comm J Qual Patient safety. 2007;33(9):537–42.CrossRefGoogle Scholar
  17. 17.
    Deal EN, Liu A, Wise LL, Honick KA, Tobin GS. Inpatient insulin orders: are patients getting what is prescribed? J Hosp Med. 2011;6(9):526–9.CrossRefPubMedGoogle Scholar
  18. 18.
    Sinha Gregory N, Seley JJ, Gerber LM, Tang C, Brillon D. Decreased rates of hypoglycemia following implementation of a comprehensive computerized insulin order set and titration algorithm in the inpatient setting. Hosp Pract. 2016;44(5):260–5.CrossRefGoogle Scholar
  19. 19.
    Moghissi ES, Korytkowski MT, DiNardo M, Einhorn D, Hellman R, Hirsch IB, et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009;32(6):1119–31.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Engle M, Ferguson A, Fields W. A journey to improved inpatient glycemic control by redesigning meal delivery and insulin administration. Clin Nurse Spec CNS. 2016;30(2):117–24.CrossRefPubMedGoogle Scholar
  21. 21.
    •• Milligan PE, Bocox MC, Pratt E, Hoehner CM, Krettek JE, Dunagan WC. Multifaceted approach to reducing occurrence of severe hypoglycemia in a large healthcare system. Am J Health Syst Pharm. 2015;72(19):1631–41. This study reports the results of implementing glucometric measurements, standardized order sets and policies as well as best practices for diabetes care in 13 hospitals. It is an excellent example of a relatively low cost targeted intervetion and shows the additional value one achieves with implementing a predictive alert for hypoglycemia. CrossRefPubMedGoogle Scholar
  22. 22.
    Jones GC, Casey H, Perry CG, Kennon B, Sainsbury CA. Trends in recorded capillary blood glucose and hypoglycaemia in hospitalised patients with diabetes. Diabetes Res Clin Pract. 2014;104(1):79–83.CrossRefPubMedGoogle Scholar
  23. 23.
    Lee YY, Lin YM, Leu WJ, Wu MY, Tseng JH, Hsu MT, et al. Sliding-scale insulin used for blood glucose control: a meta-analysis of randomized controlled trials. Metab Clin Exp. 2015;64(9):1183–92.CrossRefPubMedGoogle Scholar
  24. 24.
    Elliott MB, Schafers SJ, McGill JB, Tobin GS. Prediction and prevention of treatment-related inpatient hypoglycemia. J Diabetes Sci Technol. 2012;6(2):302–9.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Rajendran R, Rayman G. Serious harm from inpatient hypoglycaemia: a survey of hospitals in the UK. Diabet Med. 2014;31(10):1218–21.CrossRefPubMedGoogle Scholar
  26. 26.
    Schafers S, Naunheim R, Vijayan A, Tobin G. Incidence of hypoglycemia following insulin-based acute stabilization of hyperkalemia treatment. J Hosp Med. 2012;7(3):239–42.CrossRefPubMedGoogle Scholar
  27. 27.
    Coca A, Valencia AL, Bustamante J, Mendiluce A, Floege J. Hypoglycemia following intravenous insulin plus glucose for hyperkalemia in patients with impaired renal function. PLoS One. 2017;12(2):e0172961.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Wheeler DT, Schafers SJ, Horwedel TA, Deal EN, Tobin GS. Weight-based insulin dosing for acute hyperkalemia results in less hypoglycemia. J Hosp Med. 2016;11(5):355–7.CrossRefPubMedGoogle Scholar
  29. 29.
    Deusenberry CM, Coley KC, Korytkowski MT, Donihi AC. Hypoglycemia in hospitalized patients treated with sulfonylureas. Pharmacotherapy. 2012;32(7):613–7.CrossRefPubMedGoogle Scholar
  30. 30.
    Lipska KJ, Ross JS, Wang Y, Inzucchi SE, Minges K, Karter AJ, et al. National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011. JAMA Intern Med. 2014;174(7):1116–24.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Umpierrez GE, Smiley D, Hermayer K, Khan A, Olson DE, Newton C, et al. Randomized study comparing a basal-bolus with a basal plus correction insulin regimen for the hospital management of medical and surgical patients with type 2 diabetes: basal plus trial. Diabetes Care. 2013;36(8):2169–74.CrossRefPubMedPubMedCentralGoogle Scholar
  32. 32.
    Umpierrez GE, Smiley D, Zisman A, Prieto LM, Palacio A, Ceron M, et al. Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial). Diabetes Care. 2007;30(9):2181–6.CrossRefPubMedGoogle Scholar
  33. 33.
    Umpierrez GE. Inpatient management of diabetes: an increasing challenge to the hospitalist physician. J Hosp Med. 2007;2(Suppl 1):33–5.CrossRefPubMedGoogle Scholar
  34. 34.
    Pasquel FJ, Gianchandani R, Rubin DJ, Dungan KM, Anzola I, Gomez PC, et al. Efficacy of sitagliptin for the hospital management of general medicine and surgery patients with type 2 diabetes (Sita-Hospital): a multicentre, prospective, open-label, non-inferiority randomised trial. Lancet Diabetes Endocrinol. 2017;5(2):125–33.CrossRefPubMedGoogle Scholar
  35. 35.
    •• Aloi J, Bode BW, Ullal J, Chidester P, RS MF, Bedingfield AE, et al. Comparison of an electronic glycemic management system versus provider-managed subcutaneous basal bolus insulin therapy in the hospital setting. J Diabetes Sci Technol. 2017;11(1):12–6. This study was a crossover multicenter study looking at 999 non ICU patients comparing electronic glycemic management (EGM) versus provider directed basal bolus therapy. The study showed that the EGM group achieved improved glycemic control with lower incidence of hypoglycemia (<40 mg/dL and <70 mg/dl) compared to basal bolus treatment managed by a provider. CrossRefPubMedGoogle Scholar
  36. 36.
    Baldwin D, Zander J, Munoz C, Raghu P, DeLange-Hudec S, Lee H, et al. A randomized trial of two weight-based doses of insulin glargine and glulisine in hospitalized subjects with type 2 diabetes and renal insufficiency. Diabetes Care. 2012;35(10):1970–4.CrossRefPubMedPubMedCentralGoogle Scholar
  37. 37.
    Lee SY, Askin G, McDonnell ME, Arnold LM, Alexanian SM. Hypoglycemia rates after restriction of high-dose glargine in hospitalized patients. Endocr Pract. 2016;22(12):1393–400.CrossRefPubMedGoogle Scholar
  38. 38.
    •• Maynard GA, Childers D, Holdych J, Kendall H, Hoag T, Harrison K. Improving glycemic control safely in non-critical care patients: a collaborative systems approach in nine hospitals. Jt Comm J Qual Patient Saf. 2017;43(4):179–88. This study reports the results of implementing glucometric measurements, standardized order sets and policies as well as best practices for diabetes care in 9 hospitals. It is an excellent example of a relatively low cost targeted intervetion. CrossRefPubMedGoogle Scholar
  39. 39.
    Bellido V, Suarez L, Rodriguez MG, Sanchez C, Dieguez M, Riestra M, et al. Comparison of basal-bolus and premixed insulin regimens in hospitalized patients with type 2 diabetes. Diabetes Care. 2015;38(12):2211–6.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    • Kilpatrick CR, Elliott MB, Pratt E, Schafers SJ, Blackburn MC, Heard K, et al. Prevention of inpatient hypoglycemia with a real-time informatics alert. J Hosp Med. 2014;9(10):621–6. This study was a prospective cohort study showing the value of a predictive hypoglycemia alert in an academic medical center. The alert process resulted in a significant decrease by 68% in the rate of SH in alerted high-risk patients versus nonalerted high-risk patients (3.1% vs 9.7%, P = 0.012). It was subsequently utilized in reference 21 above. CrossRefPubMedGoogle Scholar
  41. 41.
    • Rushakoff RJ, Sullivan MM, HW MM, Shah AD, Rajkomar A, Glidden DV, et al. Association between a virtual glucose management service and glycemic control in hospitalized adult patients: an observational study. Ann Intern Med. 2017;166(9):621–7. This study reports the value of a remote intervention and monitoring process targeting patients with persistent hyperglycemia as defined by 2 or more glucose values >12.5 mmol/l (225 mg/dl) or < 3.9 mmol/l ( 70mg/dl) in the last 24 hours. A virtual consult recommendation was placed in the patients electronic medical record after a virtual review of the chart. The recommendations were then reviewed by the patient’s treating providers and could then be implemented. The virtual consult process reduced hypoglycemia and improved the rates of hyperglycemia. CrossRefPubMedGoogle Scholar
  42. 42.
    Akirov A, Dicker D, Shochat T, Shimon I. Mortality risk in admitted patients with diabetes mellitus according to treatment. J Diabetes Complicat. 2016;30(6):1025–31.CrossRefPubMedGoogle Scholar
  43. 43.
    Lowden E, Schmidt K, Mulla I, Andrei AC, Cashy J, Oakes DJ, et al. Evaluation of outcomes and complications in patients who experience hypoglycemia after cardiac surgery. Endocr Pract. 2017;23(1):46–55.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  • Paulina Cruz
    • 1
  • Mary Clare Blackburn
    • 1
  • Garry S. Tobin
    • 1
  1. 1.Division of Endocrinology, Metabolism and Lipid ResearchWashington University in St. LouisSt. LouisUSA

Personalised recommendations